Japan’s Efforts For ‘Zero’ Device Lag To Guide EU?
This article was originally published in PharmAsia News
Japan aims to achieve “zero” review lag for medical devices by introducing new measures for products coming into the system and taking action to speed up reviews of devices already underway. It is taking a different approach according to how urgent the review is, or how urgently the product is needed.
You may also be interested in...
Despite the urgency to have many more notified bodies designated under the MDR and IVDR, COVID-19 fall-out has resulted in a hiatus in their appointment, Commission figures show.
The EU’s IVD Regulation is going to apply just a year later than the EU’s MDR. Where are the gaps and how can industry manage the IVD notified body shortage?
The start date for voluntary registration in the Eudamed 3 database is fast approaching. It is open to all medtech manufacturers with CE marked medical devices from 1 December.